Dr. Xiang Qi Werdich, MD, PhD

Dr. Werdich practices at Jamaica Plain VA Medical Center in Jamaica Plain, Massachusetts, part of Veterans Health Administration.

Dr. Werdich's NPI, 1124289749, was assigned on June 17, 2008. Dr. Werdich holds Massachusetts license 250826.

Dr. Werdich's primary practice is Jamaica Plain VA Medical Center, at 150 S. Huntington Avenue, Jamaica Plain, MA 02130 in Suffolk County. The practice phone is (617) 232-9500.

Dr. Werdich's primary practice is Jamaica Plain VA Medical Center in Jamaica Plain, Massachusetts, part of Veterans Health Administration. Dmand AI also links Dr. Werdich to 2 medical groups and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Werdich practices, 2 sites in all. Vendor and product names are available with a free account.

Retina specialist is Dr. Werdich's primary specialty in the NPI Registry, under taxonomy code 207WX0107X. Dr. Werdich is board certified in ophthalmology by the American Board of Ophthalmology. Dr. Werdich is licensed in Massachusetts.

CMS data shows 1,241 Medicare services from Dr. Werdich across 6 procedure codes in 2024, for 184 Medicare patients. Medicare paid $71,863 for them. Every service was in an office.

CMS counts 184 Medicare patients who saw Dr. Werdich in 2024. The largest group is 75 to 84, with 81 patients. 75% of them have high cholesterol, and 71% have high blood pressure. 9% are also on Medicaid. Their average risk score is 1.20, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Werdich's median patient age at 73, with 57% women.

In 2024, Dr. Werdich wrote 107 Medicare Part D claims for 37 patients. 55% of them were for generic drugs. CMS names the drug for 58 of them, across 3 drugs with 11 or more claims each, at $8,896 in total drug cost. In 2023, CMS named 29 claims across 2 drugs.

Dr. Werdich accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Cataract surgery: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 8 papers to Dr. Werdich, published from 2012 to 2014. 2013 was the busiest year, with 3. The most frequent topics are Biomarkers, Tumor, Conjunctival Neoplasms and Genetic Testing. Dr. Werdich has published most often in Am J Ophthalmol. Dr. Werdich's most frequent co-authors are James Chodosh, MD, MPH, Judy A. Estroff, MD and Suzanne K. Freitag, MD.

CMS Open Payments shows 29 general payments to Dr. Werdich from 11 drug and device companies from 2018 to 2024. Food and beverage make up the largest share, 97% of the total. Regeneron Pharmaceuticals, Inc. paid the most, $337.